ARX Equity Partners exits DC Bled

Medical diagnostics

ARX Equity Partners has sold its investment in Slovenian healthcare services provider Diagnosticni Center Bled doo (DCB), generating an overall 3.6x cash-on-cash return multiple and an IRR exceeding 25 per cent.

DCB has been acquired by a joint venture involving Sava Re and Triglav, two of Slovenia’s largest insurance companies.

The takeover of DC Bled represents an important step for Sava Re and Triglav, respectively, towards the implementation of their strategic expansion into the Slovenian private health services market, according to a statement.

“We are delighted that DC Bled has been acquired by a blue-chip strategic investor, one that will continue to support the company in its objective to provide the highest quality medical services to the Slovenian market,” said Brian Wardrop, managing partner at ARX.

“We want to thank the DC Bled management team, led by CEO Zvone Novina, for the exceptional cooperation with ARX during this sale process and we wish them continued success with this new chapter,” added Wardrop.

ARX acquired DCB in 2015 to develop its business and best-in-class, specialist medical capabilities as a platform to further consolidate and grow its market leading position in the Slovenian diagnostics sector, according to the firm.

During the period of ARX’s ownership it completed four strategic add-on acquisitions.

ARX has a 20-year track record supporting the growth and development of mid-sized companies in Central Europe. Its portfolio includes Skanska LOP, Fontana and Deva Nutrition.

Author Profile
Mark Kitchen
Employee title
News Editor